Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China
· Delayed Price · Currency is CNY 13.05
+0.04 (0.31%)
At close: Apr 30, 2025, 2:57 PM CST
SHE:301246 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Jan '21 Jan 1, 2021 | 2015 - 2019 |
| Net Income | 29.15 | 51.46 | 87.17 | 434.8 | 493.85 | 257.18 | Upgrade
|
| Depreciation & Amortization | 178.63 | 178.63 | 156.86 | 89.8 | 80.36 | 74.37 | Upgrade
|
| Other Amortization | 3.36 | 3.36 | 4.46 | 6.14 | 5.52 | 3.11 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.53 | -0.53 | -0.57 | -14.44 | 0 | -1.88 | Upgrade
|
| Asset Writedown & Restructuring Costs | 31.26 | 31.26 | - | 1.97 | 7.88 | 9.89 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.42 | -1.42 | -20.99 | -169.14 | -190.23 | 15.15 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | -2.55 | 4.29 | 1.03 | 0.07 | Upgrade
|
| Other Operating Activities | 1.56 | 13.33 | 46.45 | 38.7 | 7.45 | 21.13 | Upgrade
|
| Change in Accounts Receivable | -168.43 | -168.43 | -152.75 | -494.66 | -289.98 | -155.24 | Upgrade
|
| Change in Inventory | -74.75 | -74.75 | 135.06 | -178.49 | -81.72 | -63.5 | Upgrade
|
| Change in Accounts Payable | -57.73 | -57.73 | -221.78 | 498.4 | 165.33 | -18.51 | Upgrade
|
| Change in Other Net Operating Assets | 8.62 | 8.62 | - | - | - | - | Upgrade
|
| Operating Cash Flow | -49.9 | -15.81 | 35.25 | 214.99 | 196.1 | 142.39 | Upgrade
|
| Operating Cash Flow Growth | - | - | -83.60% | 9.63% | 37.71% | -39.72% | Upgrade
|
| Capital Expenditures | -31.82 | -160.2 | -474.64 | -507.09 | -259.01 | -56.86 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.35 | 1.36 | 1.14 | 104.26 | 1.33 | 152.75 | Upgrade
|
| Cash Acquisitions | -3.2 | -3.2 | - | - | - | - | Upgrade
|
| Investment in Securities | -91.57 | 514.05 | -1,596 | 33 | 0.01 | 2.87 | Upgrade
|
| Other Investing Activities | - | 61.5 | - | - | - | 0.79 | Upgrade
|
| Investing Cash Flow | -125.25 | 413.51 | -2,069 | -369.83 | -257.67 | 99.55 | Upgrade
|
| Long-Term Debt Issued | - | 51.14 | 21.25 | 494.5 | 110 | 199.98 | Upgrade
|
| Total Debt Issued | 169.51 | 51.14 | 21.25 | 494.5 | 110 | 199.98 | Upgrade
|
| Long-Term Debt Repaid | - | -65.55 | -98.28 | -55.07 | -188.85 | -354.46 | Upgrade
|
| Total Debt Repaid | -70.55 | -65.55 | -98.28 | -55.07 | -188.85 | -354.46 | Upgrade
|
| Net Debt Issued (Repaid) | 98.96 | -14.42 | -77.02 | 439.43 | -78.85 | -154.48 | Upgrade
|
| Issuance of Common Stock | - | - | 2,196 | - | - | - | Upgrade
|
| Common Dividends Paid | -31.03 | -30.86 | -53.8 | -14.97 | -2.22 | -8.74 | Upgrade
|
| Dividends Paid | -31.03 | -30.86 | -53.8 | -14.97 | -2.22 | -8.74 | Upgrade
|
| Other Financing Activities | -121.63 | -131.62 | 88.07 | -134.32 | 15.27 | 8.68 | Upgrade
|
| Financing Cash Flow | -53.7 | -176.9 | 2,153 | 290.13 | -65.79 | -154.54 | Upgrade
|
| Foreign Exchange Rate Adjustments | 4.35 | 4.98 | 0.57 | 5.65 | -1.13 | -7.57 | Upgrade
|
| Net Cash Flow | -224.5 | 225.78 | 119.68 | 140.94 | -128.49 | 79.83 | Upgrade
|
| Free Cash Flow | -81.72 | -176.01 | -439.39 | -292.1 | -62.92 | 85.53 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | -36.51% | Upgrade
|
| Free Cash Flow Margin | -4.60% | -9.94% | -21.38% | -14.15% | -3.99% | 6.57% | Upgrade
|
| Free Cash Flow Per Share | -0.20 | -0.44 | -1.13 | -0.83 | -0.18 | 0.24 | Upgrade
|
| Cash Income Tax Paid | - | -19.15 | 67.14 | 45.74 | 89.49 | 87.38 | Upgrade
|
| Levered Free Cash Flow | -98.65 | -152.01 | -511.5 | 120.97 | 53.49 | 213.49 | Upgrade
|
| Unlevered Free Cash Flow | -98.65 | -152.01 | -503.13 | 123.1 | 54.98 | 223.15 | Upgrade
|
| Change in Net Working Capital | 294.29 | 227.62 | 229.79 | -370.84 | -5.54 | 18.57 | Upgrade
|
Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.